Early onset Alzheimer's disease in a large Swiss family

Schweizer Archiv fur Neurologie und Psychiatrie

Volumn 149, Issue 4, 1998, Pages 170-177

  Leuba, G ^a   Saini, K ^a   Schwed, P ^a   Lannfelt, L ^b   Savioz, A ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Hop Universitaires de Genève   (Belgium)

Author keywords

Clinics; Familial Alzheimer's disease; Genetics; Neuronal degeneration

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 21; HEREDITY; HUMAN; ONSET AGE; RISK FACTOR; SWITZERLAND;

EID: 0032426072     PISSN: 02587661     EISSN: None     Source Type: Journal    
DOI: 10.4414/sanp.1998.01047     Document Type: Article

References (35)

1. Van Broeckhoven C. Presenilins and Alzheimer's disease. Nature Genet 1995;11:230-2.
2. Ashall F, Goate AM. Role of the β-amyloid precursor protein in Alzheimer's disease. Trends Biochem Sci 1994;19:42-6.
3. Schellenberg GD. Genetic dissection of Alzheimer's disease, a heterogeneous disorder. Proc Natl Acad Sci 1995;92:8552-9.
4. Edelberg HK, Wei JY. The biology of Alzheimer's disease. Mech Ageing Dev 1996;91:95-114.
5. Hendriks L, Van Broeckhoven C. The β-A4 amyloid precursor protein gene and Alzheimer's disease. Eur J Biochem 1996;237:6-15.
6. Giannakopoulos P, Hof PR, Savioz A, Guimon J, Antonarakis SE, Bouras C. Early-onset dementias - clinical, neuropathological and genetic characteristics. Acta Neuropathol 1996;91:451-65.
7. Levy-Lahad E, Bird TD. Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol 1996;40:829-40.
8. Lannfelt L. Genetics of Alzheimer's disease. Acta Neurol Scand 1994;168:25-7.
9. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154-9.
10. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997;275:630-1.
11. Rohan de Silva HA, Patel AJ. Presenilins and early-onset familial Alzheimer's disease. Neuroreport 1997;8:i-xii.
12. Uterman G. The apolipoprotein E connection. Current Biology 1994;4:362-5.
13. Kamboh MI. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum Biol 1995;67:195-215.
14. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995;38:6-14.
15. Poirier J, Minnich A, Davignon J. Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann Med 1995;27:663-70.
16. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Ann Rev Med 1996;47:387-400.
17. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Ann Rev Neurosci 1996;19:53-77.
18. Mayeux R, Schupf N. Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine. Am J Pub Health 1995;85:1280-4.
19. Masliah E, Mallory M, Veinbergs I, Miller A, Samuel W. Alterations in apolipoprotein E expression during aging and neurodegeneration. Prog Neurobiol 1996;50:493-503.
20. Higgins GA, Large CH, Rupniak HT, Barnes JC. Apolipoprotein E and Alzheimer's disease: a review of recent studies. Pharm Biochem Behav 1997;56:675-85.
21. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Physisch-Gerichtliche Medizin 1907;64:146-8.
22. Fisman M, Ramsay D, Weiser M. Dementia in the elderly male alcoholic - a retrospective clinicopathological study. Int J Ger Psychiatry 1996;11:209-18.
23. Fratiglioni L. Epidemiology of Alzheimer's disease and current possibilities for prevention. Acta Neurol Scand 1996;93:33-40.
24. Jost BC, Grossberg GT. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc 1996;44:1078-81.
25. Aksari P, Stoppe G. Risk factors in Alzheimer's dementia. Fortschritte der Neurologie-Psychiatrie 1996;64:425-32.
26. Lantos PL, Luthert PJ, Hanger D, Anderton BH, Mullan M, Rossor M. Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett 1992;137:221-4.
27. Cairns NJ, Chadwick A, Lantos PL, Levy R, Rossor MN. Beta-A4-protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta-A4-amyloid precursor protein gene and sporadic Alzheimer's disease. Neurosci Lett 1993;149:137-40.
28. Hof PR, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J Comp Neurol 1990;301:55-64.
29. Delacoste MC, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis - a review and model system. Neurobiol Aging 1993;14:1-16.
30. Rebeck GW, Hyman BT. Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease. Neurobiol Aging 1993;14:45-7.
31. Leuba G, Kraftsik R. Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks. Neurobiol Aging 1994;15:29-43.
32. Leuba G, Saini K. Pathology of subcortical visual centers in relation to cortical degeneration in Alzheimer's disease. Neuropathol Appl Neurobiol 1995;21:410-22.
33. Terry RD, Masliah E, Salmon DP, Butters N, De Teresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80.
34. Samuel W, Terry RD, De Teresa R, Butters N, Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer's dementia. Arch Neurol 1994;51:772-8.
35. Nagy Z, Jobst KA, Esiri MM, Morris JH, King EMF, Macdonald B, et al. Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease-clinicopathologic correlations using three sets of pathologic diagnostic criteria. Dementia 1996;7:76-81.